ZEVRA THERAPEUTICS, INC. ZVRA
CIK 0001434647
Form 4 transactions dated Sep 1, 2023 to Sep 23, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $562.16K
- Sold
- $3.65M
Sep 1, 2023 – Aug 17, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2026-08-14 | Thompson Rahsaan Chief Legal & Compliance | Sale10b5-1 footnote | $474.77K 42,666 shares sold | 53.18% sold Direct holding | ▾ |
| 2026-08-10 | Watton Corey Michael Director | Sale | $138.38K 12,300 shares sold | 87.23% sold Direct holding | ▾ |
| 2026-06-22 | Thompson Rahsaan Chief Legal & Compliance | Sale10b5-1 footnote | $438.30K 34,557 shares sold | 30.10% sold Direct holding | ▾ |
| 2026-05-11 | Thompson Rahsaan Chief Legal & Compliance | Sale10b5-1 footnote | $20.27K 1,794 shares sold | 3.59% sold Direct holding | ▾ |
| 2026-02-09 | McFarlane Neil F. President and CEO · Director | Sale10b5-1 footnote | $125.19K 14,625 shares sold | 3.64% sold Direct holding | ▾ |
| 2026-02-03 | Schafer Joshua CCO | Sale10b5-1 footnote | $96.50K 10,500 shares sold | 14.43% sold Direct holding | ▾ |
| 2026-02-03 | Sangiovanni Timothy J. SVP, Finance & Corp Controller | Sale10b5-1 footnote | $27.55K 3,000 shares sold | 9.21% sold Direct holding | ▾ |
| 2026-02-02 | McFarlane Neil F. President and CEO · Director | Sale10b5-1 footnote | $853.43K 91,000 shares sold | 19.98% sold Direct holding | ▾ |
| 2026-01-30 | Schafer Joshua CCO | Sale10b5-1 footnote | $29.80K 3,375 shares sold | 8.27% sold Direct holding | ▾ |
| 2026-01-30 | Quartel Adrian W Chief Medical Officer | Sale10b5-1 footnote | $40.04K 4,533 shares sold | 31.80% sold Direct holding | ▾ |
Showing 12 / 12 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 12 of 12 purchase / sale groups and 30 of 40 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"ZVRA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.